Early research (Phase 1)Ended earlyNCT04598321What this trial is testingBrUOG 390: Neoadjuvant Treatment With TalazoparibWho this might be right forBRCA1 MutationBRCA2 MutationOvarian Cancer+2 more Brown University 1
Testing effectiveness (Phase 2)Looking for participantsNCT06682988What this trial is testingAssess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab SoravtansineWho this might be right forAdvanced High-Grade Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancers AbbVie 110
Not applicableEnded earlyNCT03922776What this trial is testingPhenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IV+1 more Centre Oscar Lambret 36
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05257408What this trial is testingRelacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerWho this might be right forOvarian NeoplasmFallopian Tube NeoplasmsPeritoneal Neoplasms Corcept Therapeutics 381
Testing effectiveness (Phase 2)Study completedNCT03648489What this trial is testingDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more Imperial College London 134
Testing effectiveness (Phase 2)Looking for participantsNCT07125391What this trial is testingChemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian CancerWho this might be right forOvarian Cancer Bai-Rong Xia 136
Early research (Phase 1)Looking for participantsNCT06084481What this trial is testingStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Who this might be right forHepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more AbbVie 325
Large-scale testing (Phase 3)Study completedNCT04296890What this trial is testingMirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionWho this might be right forEpithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer ImmunoGen, Inc. 106
Not applicableActive Not RecruitingNCT04454450What this trial is testingUsing Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian CancerWho this might be right forOvarian CancerHigh Grade Ovarian Serous Memorial Sloan Kettering Cancer Center 10
Large-scale testing (Phase 3)UnknownNCT05622890What this trial is testingA Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian CancerWho this might be right forEpithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT02354586What this trial is testingNiraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy RegimensWho this might be right forOvarian NeoplasmsOvarian Cancer Tesaro, Inc. 463
Very early researchStudy completedNCT02316834What this trial is testingTalazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaOvarian Mass+16 more M.D. Anderson Cancer Center 4
Early research (Phase 1)Ended earlyNCT05194072What this trial is testingFelmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsWho this might be right forOvarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms+8 more Seagen, a wholly owned subsidiary of Pfizer 250
Testing effectiveness (Phase 2)Looking for participantsNCT06843447What this trial is testingA Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Who this might be right forOvarian Cancer Recurrent Merck Sharp & Dohme LLC 605
Very early researchActive Not RecruitingNCT02659241What this trial is testingAdavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+19 more M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432594What this trial is testingNeoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian CancerWho this might be right forHigh-grade Serous Ovarian Cancer (HGSOC)Fallopian Tube CancersPrimary Peritoneal Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 82
Testing effectiveness (Phase 2)Study completedNCT02797964What this trial is testingA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerWho this might be right forAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Sierra Oncology LLC - a GSK company 107